Tenaris S.A. (TS) PT Raised to $46 at TD Cowen

TD Cowen analyst Marc Bianchi raised the price target on Tenaris S.A. (NYSE: TS) to $46.00 (from $43.00) while maintaining a Buy rating.

The analyst comments "TS outperformed the OIH by ~400bps after a better than expected print and 4Q guide as they appear to be managing through incremental tariff costs. An eventual improvement in US prices, optimizing cost structure, or better mix in 2026 should drive EBITDA higher from the guided 4Q runrate. We also see potential upside to 4Q from a greater proportion of OCTG mix."

You May Also Be Interested In

• Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
• Anthropic Said In Talks To Buy Ai Startup Decart For $6 Billion - Bloomberg
• Nomura/Instinet Downgrades Pearl Abyss Corp. (263750:KS) (BRFS) to Neutral